{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=29&state=Kentucky", "query": { "state": "Kentucky", "city": "Louisville", "page": 29 }, "page_size": 10 }, "pagination": { "page": 29, "page_size": 10, "total_count": 1177, "total_pages": 118, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=30&state=Kentucky&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=28&state=Kentucky&page_size=10" }, "source": "local", "last_synced_at": "2026-10-17T08:30:14.021Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07796230", "title": "Modified P200TE Data Collection", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Retina Disease" ], "interventions": [ { "name": "imaging device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Optos, PLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 50, "start_date": "2026-07-29", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-16T11:56:03.695Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT07796230" }, { "nct_id": "NCT06854458", "title": "The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiac Magnetic Resonance Imaging", "Ischemic Heart Disease (IHD)", "Myocardial Blood Flow" ], "interventions": [ { "name": "Blood draw for the laboratory assessment", "type": "DIAGNOSTIC_TEST" }, { "name": "Gadavist", "type": "DRUG" }, { "name": "Qualitative Myocardial Blood Flow Evaluation", "type": "DIAGNOSTIC_TEST" }, { "name": "Quantitative Myocardial Blood Flow Evaluation", "type": "DIAGNOSTIC_TEST" }, { "name": "Vasodilator", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "35 Years to 85 Years" }, "enrollment_count": 1000, "start_date": "2025-06-27", "completion_date": "2029-03", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-16T04:27:08.732Z", "location_count": 13, "location_summary": "San Francisco, California • Louisville, Kentucky • Boston, Massachusetts + 9 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Roslyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06854458" }, { "nct_id": "NCT04546399", "title": "A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Down Syndrome", "Recurrent B Acute Lymphoblastic Leukemia" ], "interventions": [ { "name": "3-Dimensional Conformal Radiation Therapy", "type": "RADIATION" }, { "name": "Asparaginase Erwinia chrysanthemi", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Blinatumomab", "type": "BIOLOGICAL" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Calaspargase Pegol", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Hydrocortisone Sodium Succinate", "type": "DRUG" }, { "name": "Lumbar Puncture", "type": "PROCEDURE" }, { "name": "Mercaptopurine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Pegaspargase", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Year to 30 Years" }, "enrollment_count": 461, "start_date": "2020-12-17", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-17T08:30:14.021Z", "location_count": 211, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 151 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Kingman", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04546399" }, { "nct_id": "NCT04262206", "title": "Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cardiovascular Diseases", "Cognitive Impairment, Mild", "Dementia" ], "interventions": [ { "name": "Atorvastatin 40 Mg Oral Tablet", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "75 Years", "maximum_age": null, "sex": "ALL", "summary": "75 Years and older" }, "enrollment_count": 20000, "start_date": "2020-09-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-15T19:37:21.036Z", "location_count": 104, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 70 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04262206" }, { "nct_id": "NCT06513962", "title": "Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hematopoietic and Lymphatic System Neoplasm", "Malignant Solid Neoplasm" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" }, { "name": "Triptorelin Pamoate", "type": "DRUG" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DRUG" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "39 Years", "sex": "FEMALE", "summary": "Up to 39 Years · Female only" }, "enrollment_count": 60, "start_date": "2025-02-27", "completion_date": "2029-10-30", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-10-15T23:44:07.577Z", "location_count": 201, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 143 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06513962" }, { "nct_id": "NCT07096193", "title": "Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Hepatitis Delta" ], "interventions": [ { "name": "GS-4321", "type": "DRUG" }, { "name": "GS-4321 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 200, "start_date": "2025-07-31", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-10-15T23:35:06.197Z", "location_count": 5, "location_summary": "Anaheim, California • La Jolla, California • Louisville, Kentucky + 2 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07096193" }, { "nct_id": "NCT06953674", "title": "Saline Versus Balanced Crystalloid in Traumatic Brain Injury", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Traumatic Brain Injury (TBI) Patients" ], "interventions": [ { "name": "Normal Saline (0.9% NaCl)", "type": "DRUG" }, { "name": "balanced crystalloid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Louisville", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2025-06-01", "completion_date": "2029-09", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-15T01:09:40.921Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT06953674" }, { "nct_id": "NCT06388421", "title": "DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Interstitial Lung Disease", "Pulmonary Hypertension", "Pulmonary Hypertension Due to Lung Diseases and Hypoxia" ], "interventions": [ { "name": "Prospective study assessments", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "United Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 900, "start_date": "2025-01-23", "completion_date": "2030-11-30", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-14T16:42:58.152Z", "location_count": 70, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06388421" }, { "nct_id": "NCT07466316", "title": "A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhabdomyosarcoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Dactinomycin", "type": "BIOLOGICAL" }, { "name": "Irinotecan Hydrochloride", "type": "DRUG" }, { "name": "Lumbar Puncture", "type": "PROCEDURE" }, { "name": "Lymph Node Biopsy", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Resection", "type": "PROCEDURE" }, { "name": "Survey Administration", "type": "OTHER" }, { "name": "Vincristine Sulfate", "type": "DRUG" }, { "name": "Vinorelbine Tartrate", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL", "RADIATION", "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "50 Years", "sex": "ALL", "summary": "Up to 50 Years" }, "enrollment_count": 342, "start_date": "2026-07-14", "completion_date": "2031-03-31", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-15T18:22:08.879Z", "location_count": 86, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Little Rock, Arkansas + 71 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Duarte", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07466316" }, { "nct_id": "NCT07018323", "title": "A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graves' Disease" ], "interventions": [ { "name": "IMVT-1402", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Immunovant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 210, "start_date": "2025-06-19", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-14T08:38:35.101Z", "location_count": 33, "location_summary": "Tucson, Arizona • Concord, California • Aurora, Colorado + 28 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Concord", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Doral", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07018323" } ] }